CHMP Recommended Granting Marketing Authorization For Elahere For The Treatment Of Adults With Ovarian Cancer, Fallopian Tube Cancer, Or Primary Peritoneal Cancer
CHMP Recommended Granting Marketing Authorization For Elahere For The Treatment Of Adults With Ovarian Cancer, Fallopian Tube Cancer, Or Primary Peritoneal Cancer
CHMP建議授予Elahere治療卵巢癌、輸卵管癌或原發性腹膜癌的成年人的市場授權。
CHMP Recommended Granting Marketing Authorization For Elahere For The Treatment Of Adults With Ovarian Cancer, Fallopian Tube Cancer, Or Primary Peritoneal Cancer
CHMP建議授予Elahere治療卵巢癌、輸卵管癌或原發性腹膜癌的成年人的市場授權。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間